Growth inhibition of head and neck carcinomas by D-allose

Head and Neck

Volumn 31, Issue 8, 2009, Pages 1049-1055

  Mitani, Tomoo ^a   Hoshikawa, Hiroshi ^a   Mori, Terushige ^a   Hosokawa, Tomohiro ^a   Tsukamoto, Ikuko ^a   Yamaguchi, Fuminori ^a   Kamitori, Kazuyo ^a   Tokuda, Masaaki ^a   Mori, Nozomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle; D allose; Growth inhibition; Head and neck carcinomas

Indexed keywords

ALLOSE; FRUCTOSE; GLUCOSE; MESSENGER RNA; PSICOSE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL ASSAY; CELL CYCLE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU NICK-END LABELING; MOUTH NEOPLASMS; PROBABILITY; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 67650421884     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21070     Document Type: Article

References (17)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2002;52:23-47.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
3. Pignon J, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949-955. (Pubitemid 30148259)
4. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-194.
5. Rapidis AD, Trichas M, Stavrinidis E, et al. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Oral Oncol 2006;42:675-684. (Pubitemid 44094243)
6. Bhuiyan SH, Itami Y, Rokui Y, Katayama T, Izumori K. D-Allose production from D-psicose using immobilized L-rhamnose isomerase. J Ferment Bioeng 1998;85:539-541. (Pubitemid 28283620)
7. Izumori K. Bioproduction strategies for rare sugars. Naturwissenschaften 2002;89:120-124.
8. Hossain MA, Izuishi K, Maeta H. Protective effects of D-allose against ischemia reperfusion injury of the rat liver. J Hepatobil Pancreat Surg 2003;10:218-225. (Pubitemid 37407507)
9. Kimura S, Zhang GX, Nishiyama A, et al. D-Allose, an all-cis aldo-hexose, suppresses development of salt-induced hypertension in Dahl rats. J Hypertens 2005;23: 1887-1894. (Pubitemid 41830429)
10. Murata A, Sekiya K, Watanabe Y, et al. A novel inhibitory effect of D-allose on production of reactive oxygen species from neutrophils. J Biosci Bioeng 2003;96:89-91. (Pubitemid 37026311)
11. Sui L, Dong Y, Watanabe Y, et al. The inhibitory effect and possible mechanisms of D-allose on cancer cell proliferation. Int J Oncol 2005;27:907-912.
12. Yamaguchi F, Takata M, Kamitori K, et al. Rare sugar Dallose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1. Int J Oncol 2008;32:377-385. (Pubitemid 351188304)
13. Rosenblatt J, Gu Y, Morgan D. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci U S A 1992;89:2824-2828.
14. cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998;18:629-643.
15. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 1999;39:295-312.
16. Kunkel M, Reichert TE, Benz P, et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003;97:1015-1024. (Pubitemid 36173153)
17. Pratt SE, Colby-Germinario SP, Manuel S, Germinario RJ. Evidence that modulation of glucose transporter intrinsic activity is the mechanism involved in the allose-mediated depression of hexose transport in mammalian cells. J Cell Physiol 1994;161:580-588. (Pubitemid 24372502)